BioCentury
ARTICLE | Clinical News

Intellect Neurosciences preclinical data

February 17, 2014 8:00 AM UTC

In a transgenic mouse model of AD that exhibits both beta amyloid and tau pathologies, TauC3 reduced certain phosphorylated pathological forms of tau, which Intellect said indicates that the treatmen...